Why ASP Isotopes Inc.’s (ASPI) Stock Is Down 6.91%
As of Monday, August 17, ASP Isotopes Inc.’s ASPI share price has dipped by 6.91%, which has investors questioning if this is right time to buy.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.
Commentary & Analysis
What You Need to Know About ASP Isotopes Inc.'s Q3 Earnings
ASP Isotopes Inc.'s fiscal Q3 earnings report was released on Friday, August 14. Let's dive in to see if (ASPI) missed or beat analyst's expectations.Michael Rose
Is ASP Isotopes Inc. (ASPI) Overvalued?
We dive into why ASP Isotopes Inc. (ASPI) could be considered overvalued on 2026-08-07, based on AAII’s Value Score and Grade.Rosalio Madrigal
Why ASP Isotopes Inc.’s (ASPI) Stock Is Up 6.22%
As of Friday, August 07, ASP Isotopes Inc.’s ASPI share price has surged by 6.22%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Why ASP Isotopes Inc.’s (ASPI) Stock Is Up 11.01%
As of Thursday, July 30, ASP Isotopes Inc.’s ASPI share price has surged by 11.01%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | ASPI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $591.8 | $3,986.1 | 38% |
|
| Shares Out (Mil) | 122.7 | 92.2 | 66% |
|
| Institutional Ownership | 76.7% | 82.8% | 47% |
|
| Float (Mil) | 132.7 | 117.6 | 66% |
|
| Beta | 3.62 | 0.78 | 99% |
|
| Avg Daily Volume (000s) | 3,020 | 131 | 87% |
|
| Price Change (52-week) |
(58.5%) | 85.4% | 12% |
|
| Growth | ASPI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 4.0% | na |
|
| Net Income (5yr) | na | (0.2%) | na |
|
| EPS (5yr) | na | 1.5% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.3%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 3 | |
| Current EPS | ($0.370) | ($1.435) | ($1.157) | |
| Month Ago EPS | ($0.370) | ($1.435) | ($1.157) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.263) | ($1.063) | ($1.047) | |
| Year/Year Chg | 35.0% | (32.0%) | (58.5%) | |
| Financials | ASPI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $31 | $4,298 | 16% |
|
| Net Income (TTM) (Mil) | ($132) | $58 | 9% |
|
| EPS (TTM) | ($1.219) | $0.300 | 19% |
|
| Operating Cash Flow (TTM) (Mil) | ($68) | $446 | 8% |
|
| Net Cash Flow (TTM) (Mil) | $158 | $6 | 81% |
|
| Long-Term Debt (Q1) (Mil) | $214 | $1,795 | 51% |
|
| Enterprise Value (Q1) (Mil) | $679 | $5,650 | 36% |
|
| Valuation | ASPI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.90 | 1.55 | 48% |
|
| P/E | na | 26.8 | na |
|
| Dividend Yield | 0.0% | 1.2% | 0% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | ASPI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 18.3% | 27.5% | 19% |
|
| Net Margin | (428.0%) | 3.0% | 2% |
|
| ROA | (37.3%) | 1.5% | 14% |
|
| ROE | (91.1%) | 4.0% | 10% |
|
| Liabilities to Assets | 52.0% | 54.5% | 45% |
|
| F-Score | 4 | 5 | 33% |
|
ASP Isotopes Inc. did not pass any screens on 8/18/2026.
